Krishna Institute of Medical Sciences Limited (BOM: 543308)

Krishna Institute of Medical Sciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	27,053	24,981	21,977	16,508	13,299	11,226
Other Revenue	-	-	-	-	-	0.25
Revenue	27,053	24,981	21,977	16,508	13,299	11,227
Revenue Growth (YoY)	12.88%	13.67%	33.13%	24.13%	18.46%	21.98%
Cost of Revenue	10,717	10,158	8,793	6,676	5,535	4,865
Gross Profit	16,336	14,823	13,184	9,832	7,764	6,361
Selling, General & Admin	494.75	494.75	352.46	205.01	178.24	162.46
Other Operating Expenses	8,801	7,920	6,784	4,429	3,851	3,723
Operating Expenses	10,912	9,880	8,429	5,361	4,733	4,597
Operating Income	5,425	4,944	4,755	4,471	3,031	1,764
Interest Expense	-660.34	-464.34	-293.18	-159.21	-293.02	-391.25
Interest & Investment Income	22.91	22.91	95.32	122.82	57.99	12.63
Earnings From Equity Investments	-2.71	-2.71	-	95.1	-	-
Other Non Operating Income (Expenses)	75.99	39.99	29.43	23.15	-2.9	27.38
EBT Excluding Unusual Items	4,860	4,539	4,586	4,553	2,793	1,413
Gain (Loss) on Sale of Investments	40.86	40.86	30.01	-	-	-
Gain (Loss) on Sale of Assets	3.76	3.76	6.1	-27.17	-10.79	-12.52
Other Unusual Items	12.39	12.39	226.72	42.41	7.52	4.54
Pretax Income	4,917	4,596	4,849	4,569	2,790	1,405
Income Tax Expense	1,277	1,236	1,191	1,131	735.36	254.54
Earnings From Continuing Operations	3,640	3,360	3,658	3,438	2,055	1,151
Net Income to Company	3,640	3,360	3,658	3,438	2,055	1,151
Minority Interest in Earnings	-326.6	-258.6	-294.91	-111.1	-42.6	41.11
Net Income	3,313	3,101	3,363	3,327	2,012	1,192
Net Income to Common	3,313	3,101	3,363	3,327	2,012	1,192
Net Income Growth	-3.14%	-7.78%	1.09%	65.33%	68.83%	-
Shares Outstanding (Basic)	-	400	400	397	374	372
Shares Outstanding (Diluted)	-	400	400	397	381	375
Shares Change (YoY)	-	-	0.74%	4.32%	1.42%	8.57%
EPS (Basic)	-	7.75	8.41	8.38	5.37	3.20
EPS (Diluted)	-	7.75	8.41	8.38	5.28	3.17
EPS Growth	-	-7.79%	0.35%	58.51%	66.48%	-
Free Cash Flow	-2,410	-1,263	-1,424	1,537	2,615	1,495
Free Cash Flow Per Share	-	-3.16	-3.56	3.87	6.87	3.98
Gross Margin	60.39%	59.34%	59.99%	59.56%	58.38%	56.66%
Operating Margin	20.05%	19.79%	21.63%	27.09%	22.79%	15.72%
Profit Margin	12.25%	12.42%	15.30%	20.15%	15.13%	10.62%
Free Cash Flow Margin	-8.91%	-5.05%	-6.48%	9.31%	19.67%	13.32%
EBITDA	6,863	6,231	5,828	5,120	3,661	2,399
EBITDA Margin	25.37%	24.94%	26.52%	31.01%	27.52%	21.37%
D&A For EBITDA	1,439	1,288	1,073	648.09	629.24	634.31
EBIT	5,425	4,944	4,755	4,471	3,031	1,764
EBIT Margin	20.05%	19.79%	21.63%	27.09%	22.79%	15.72%
Effective Tax Rate	25.98%	26.90%	24.56%	24.75%	26.36%	18.11%
Revenue as Reported	27,220	25,112	22,236	16,711	13,401	11,287
Advertising Expenses	-	251.59	197.39	111.51	91.81	113.01

Source: S&P Capital IQ. Standard template. Financial Sources.